En Es
Categories

Industry News

Philips Receives Global AI for Enhanced Radiology Interpretation Company of The Year Award from Frost & Sullivan

By Medimaging International staff writers
10 Mar 2020

IllustrationPhilips Healthcare (Amsterdam?, Noord-Holland) has been recognized with the 2019 Global Company of the Year Award by Frost & Sullivan, based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced radiology interpretation market. Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.

Philips' paradigm of combining physician enhancing, AI-based technologies, driven by contextual insights, and embedded into radiology workflows, is a disruptive imaging informatics strategy. It underscores the company's approach of employing clinically intelligent software to adapt to radiologists' skills and preferences. The company embeds advanced algorithms across multiple touchpoints in the radiologist workflow and patient care pathway, offering insights each step of the way. This new paradigm generates dynamic, meaningful, insight-rich findings delivered in a tailored, context-aware view, empowering radiologists to transition from volume- to value-based care.

Philips seeks to empower care teams to offer precision medicine (PM) by adopting a systems approach to patient care. Its Enterprise Diagnostic Imaging Solution is a configurable suite of informatics tools granting care teams access to vital information, and then leveraging that information to cultivate the insights needed for precision diagnosis. It combines clinical domain and operational knowledge to channel their components into solutions that propel its clinical and diagnostic service lines. The company now owns one of the industry's broadest portfolios, fueled by deep research collaborations with clinical partners and outreach for enhancing third-party informatics solutions.

Philips' AI paradigm stands out from competing approaches in three ways - contextual relevance, reduced variability, and extensibility. The system streamlines workflows and enables intuitive, robust, and reliable hanging protocols backed by an intelligent image processing engine. The company is now working toward integrating AI algorithms in its precision diagnostics platform and imaging modalities, whether developed internally, through deep customer partnerships, or integrated via third-party collaborations directly within radiologist-caregiver workflows.

"Philips provides integrated solutions and services spanning the health continuum, care levels, and settings. Its vision centers on sustainable health with the stated purpose of improving the lives of 3 billion people a year by 2030," said Siddharth Shah, Industry Manager. "To this end, the company views AI not as a point solution enabler, but as an embedded facilitator in the entire radiology workflow, delivering an enhanced, seamless experience to the radiologist. Philips has optimally harnessed its technology assets across various industries and business units with the end-goal of facilitating holistic, patient-specific insights and smart clinical decision-making at the point-of-care."

Related Links:
Philips Healthcare



E-mail Print
FaceBook Twitter Google+ Linked in

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare with a strong presence in cardio-pulmonary, oncology and women’s health
More info

More articles about Philips Healthcare

13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
09 Mar 2021
Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
Philips Healthcare (Amsterdam?, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
Read More
20 Jan 2021
Philips Acquires Capsule Technologies to Expand Leadership in Patient Care Management Solutions for Hospitals
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Capsule Technologies, Inc. (Andover, MA, USA), a provider of medical device integration and data technologies for hospitals and healthcare organizations.
Read More
05 Apr 2019
Philips Acquires Direct Radiology Teleradiology Platform
Royal Philips is expanding its radiology solutions portfolio with innovative teleradiology services, aimed at addressing the increasing shortage of radiologists, as well as the pressing need to improve access to precision diagnoses.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
22 Aug 2018
Intel and Philips Partner to Speed Up Imaging Analysis Using AI
Intel Corporation and Royal Philips have tested two healthcare use cases for deep learning inference models: one on X-rays of bones for bone-age-prediction modeling and the other on CT scans of lungs for lung segmentation. In these tests, which were conducted using Intel Xeon Scalable processors and the OpenVINO toolkit, the researchers achieved a speed improvement of 188 times for the bone-age-prediction model and 38 times for the lung-segmentation model over the baseline measurements. These tests show that healthcare organizations can implement artificial intelligence (AI) workloads without expensive hardware investments.
Read More
25 Jun 2018
Philips Acquires Remote Diagnostic Technologies to Expand Therapeutics
Royal Philips has acquired Remote Diagnostic Technologies, which offers advanced solutions for the pre-hospital market providing monitoring, cardiac therapy and data management. RDT’s portfolio of connected emergency care solutions will complement Philips’ Therapeutic Care business and strengthen its leadership position in the resuscitation and emergency care market. RDT’s acquisition will also strengthen Philips’ ability to innovate, drive digital transformation in healthcare, and enter new markets.
Read More
12 Mar 2018
Philips Launches Artificial Intelligence Platform for Healthcare
Royal Philips has launched HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. HealthSuite Insights, which made its debut at the 2018 HIMSS Conference & Exhibition (HIMSS18), gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data, and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry's first ecosystem where curated AI assets from Philips and others are readily available for license.
Read More

Additional news

15 Oct 2021
Biohit’s Innovative GastroPanel Quick Test Receives CE Mark
Biohit Healthcare’s (Helsinki, Finland) GastroPanel Quick Test, the latest innovation in its unique GastroPanel product family, is now CE marked.
Read More
15 Oct 2021
Global Point-of-Care (POC) Testing Market to Reach Nearly USD 80 Billion by 2028 due to Increasing Dominance of Infectious Diseases
The global Point-Of-Care (POC) testing market is projected to grow at a CAGR of 12.3% from USD 31.17 billion in 2020 to USD 78.85 billion by 2028, driven mainly by the increasing dominance of infectious diseases, hematological diseases, cancer, and others.
Read More
13 Oct 2021
Global Digital X-Ray Market to Surpass USD 14 Billion by 2026
The global market for digital X-ray is projected to grow at a CAGR of more than 7% from around USD 9 billion in 2020 to over USD 14 billion by 2026, amidst all the opportunities and challenges in a significantly transformed post COVID-19 marketplace.
Read More
06 Oct 2021
IHF Excellence Award 2021 for Corporate Social Responsibility in Healthcare to Be Sponsored by Seddiqi Holding
Seddiqi Holding (Dubai, UAE), a family-owned and managed group with a diverse portfolio of businesses, will sponsor the IHF 2021 Excellence Award for Corporate Social Responsibility in Healthcare to be awarded at the 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland).
Read More
01 Oct 2021
Global Operating Room Equipment Market Expected to Surpass USD 40 Billion in 2027
The global operating room (OR) equipment market was valued at around USD 30 billion in 2020 and is projected to register a CAGR of 4.2% over the forecast period to surpass USD 40 billion by 2027. The market growth is expected to be driven by a rise in the number of hospitals and investments in OR equipment, growing patient preference for minimal invasive surgeries, and increasing regulatory approvals for OR equipment.
Read More
30 Sep 2021
GE Healthcare Acquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare (Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More
22 Sep 2021
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
Read More
17 Sep 2021
44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event
The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice presenters at over 60 sessions around nursing leadership, humanizing technology, COVID-19 vaccination, the next global pandemic, etc.
Read More
17 Sep 2021
Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028
 The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising infectious diseases, technological developments, as well as increased knowledge and acceptance of tailored treatments.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions